undefined

Steven Ringel

CEO of the Kazuna Foundation and Gnome Therapeutics focusing on using AI to scale personalized gene therapies for rare disease patients; also an ultra-rare disease patient and advocate.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app